Formulation for the parenteral application of a sodium channel blocker

US6828311B2 · kind B2 · utility

Assignee

• BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

• Bernd Kruss · Biberach an der Riß, DE
• Annerose Mauz · Riedlingen, DE
• Karin Ruehr · Biberach, DE
• Jean-Marie Stassen · Bad Buchau, DE
• Claus Veit · Biberach, DE
• Klaus Wagner · Warthausen, DE

Key dates

• Filing date: May 28, 2003
• Grant date: Dec 7, 2004
• Expiry date: Jul 10, 2023

Classification

• Technology area (CPC B): Performing Operations; Transporting
• CPC primary: B82Y5/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a new formulation containing Bill 890 or one of the pharmaceutically acceptable salts thereof for parenteral administration.